DoW Pancreatic Cancer Research Program, Focused Pilot Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- May 4, 2026
- Amount
- Program total $1.2M
- Closes
- Oct 7, 2026 (in 21 days)
Similar opportunities open now
- DoW Pancreatic Cancer Research Program, Idea Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 21 days
- DoW Pancreatic Cancer Research Program, Translational Research Partnership AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 21 days
- DoW, Ovarian Cancer, Pilot AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 15 days
- DoW, Ovarian Cancer, Investigator-Initiated Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 15 days
- DoW Amyotrophic Lateral Sclerosis Research Program, Pilot Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 14 days
Classification and identifiers
- Solicitation number
- HT942526PCARPFPTA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $1.2M
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Pancreatic Cancer Research Program (PCARP) Focused Pilot Award supports the exploration and development of impactful and innovative concepts under a patient-centered focus area of pancreatic cancer research that could ultimately lead to major advancements that will have a profound effect on patients’ overall quality of life. The research this award supports should strive to produce robust preliminary data that can serve as a foundation for future clinical or real-world research application. Distinctive Features: This award mechanism allows, but does not require, preliminary data. Applications can support clinical research studies; however, this mechanism does not allow clinical trials. Preclinical animal studies do not meet the intent of this mechanism.